Skip to main content
. 2013 Mar 26;17(2):132–140. doi: 10.1007/s11102-013-0478-0

Table 2.

AEs (by preferred term) with a suspected study drug relationship reported in ≥5 % of patients

Overall patient population
N = 30
n (%)
Diarrhea 14 (46.7)
Nausea 10 (33.3)
Abdominal pain 6 (20.0)
Flatulence 6 (20.0)
Diabetes mellitus 5 (16.7)
Dizziness 5 (16.7)
Cholelithiasis 4 (13.3)
Type 2 diabetes mellitus 4 (13.3)
Increased blood glucose 3 (10.0)
Esophageal spasm 2 (6.7)
Fatigue 2 (6.7)
Hypoglycemia 2 (6.7)
Arthralgia 2 (6.7)
Paresthesia 2 (6.7)